Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Gregory S. Mellotte"'
Autor:
Gregory S Mellotte, Diya Sabu, Mary O’Reilly, Ray McDermott, Anthony O’Connor, Barbara M Ryan
Publikováno v:
Melanoma Management, Vol 7, Iss 4 (2020)
Aim: Primary gastric melanoma is a rare clinical presentation. The purpose of this review was to compare the 1-year survival in patients who underwent surgery with patients who did not receive treatment. Patients & methods: A systematic search of dat
Externí odkaz:
https://doaj.org/article/27f73785f3b2463d8b55a559ab766afe
Autor:
Laura E. Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O'Connell, Croí E. Buckley, Jennifer Arlow, Khanh Nguyen, David Mockler, Aidan D. Meade, Barbara M. Ryan, Stephen G. Maher
Publikováno v:
Cancer Research Communications. 2:1229-1243
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to be inaccura
Autor:
Stephen G. Maher, Barbara M. Ryan, Aidan D. Meade, David Mockler, Khanh Nguyen, Jennifer Arlow, Croí E. Buckley, Fiona O'Connell, Rebecca M. O'Brien, Eimear Mylod, Gregory S. Mellotte, Laura E. Kane
PRISMA 2020 checklist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9da26b8a8e5fe713bbf0ab69f928b3
https://doi.org/10.1158/2767-9764.22545287.v1
https://doi.org/10.1158/2767-9764.22545287.v1
Autor:
Stephen G. Maher, Barbara M. Ryan, Aidan D. Meade, David Mockler, Khanh Nguyen, Jennifer Arlow, Croí E. Buckley, Fiona O'Connell, Rebecca M. O'Brien, Eimear Mylod, Gregory S. Mellotte, Laura E. Kane
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to be inaccura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53451e0a6a007360f6677b2e53707e4b
https://doi.org/10.1158/2767-9764.c.6550895.v1
https://doi.org/10.1158/2767-9764.c.6550895.v1
Autor:
Kevin C. Conlon, Caroline Walker, Barbara Ryan, Niall Breslin, Yasir Basir, Gavin C. Harewood, Paul F. Ridgway, Deirdre Nally, Gregory S. Mellotte, Vikrant Parihar, Thilagraj Manoharan
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:157-162
Objective Healthcare resources are finite. Value in healthcare can be defined as patient health outcomes achieved per monetary unit spent. Attempts have been made to quantify the value of luminal endoscopy, but there is little in the medical literatu
Autor:
Laura E. Kane, Gregory S. Mellotte, Rebecca G. Lyons, Eimear Mylod, Simone Marcone, Paul F. Ridway, Finbar MacCarthy, Kevin C. Conlon, Joanne Lysaght, Barbara M. Ryan, Stephen G. Maher
Publikováno v:
Cancer Research. 82:3381-3381
Introduction: Pancreatic cancer was responsible for almost 500,000 deaths globally in 2020 according to GLOBOCAN. Pancreatic cystic lesions (PCLs) are fluid-filled protrusions either on or inside the pancreas and can either be benign or pre-malignant
Publikováno v:
Melanoma Management
Aim: Primary gastric melanoma is a rare clinical presentation. The purpose of this review was to compare the 1-year survival in patients who underwent surgery with patients who did not receive treatment. Patients & methods: A systematic search of dat
Publikováno v:
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Therapeutic Advances in Chronic Disease, Vol 11 (2020)
Cancer survival rates have significantly improved over the last number of years due to advancements in cancer therapies. Unfortunately this has come at a cost. Therapeutic side effects are feared complications of therapy that may result in decreased
Autor:
Fiona O'Connell, Barbara Ryan, Eimear Mylod, Laura E. Kane, Gregory S. Mellotte, Khanh Q. Nguyen, Croí E. Buckley, Rebecca O'Brien, Stephen G. Maher, Aidan D. Meade, Jennifer Arlow, David Mockler
Publikováno v:
Cancer Research. 81:PO-008
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreatic cancer, being responsible for ~90% of all pancreatic cancers and having a 5-year survival rate of ~8.5%. The current clinical gold-standard for diagnosis of PDA
Publikováno v:
Cancer Research. 81:PO-009
Background: Pancreatic cancer was responsible for almost 500,000 deaths globally in 2020 according to GLOBOCAN 2020. Pancreatic cystic lesions (PCLs) are fluid-filled protrusions either on or inside the pancreas. PCLs can either be benign or pre-mali